Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)

被引：0
|
作者：
Prasanth, G. [1 ]
Sharma, Atul [1 ]
机构：
[1] AIIMS, Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi 110029, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2007年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 25
页数：3
相关论文
共 50 条
  • [31] PHASE I TRIAL OF COMBINATION CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN AND S-1 IN PATIENTS WITH HEAD AND NECK CANCER
    Tahara, Makoto
    Araki, Kazuhiro
    Okano, Susumu
    Kiyota, Naomi
    Fuse, Nozomu
    Minashi, Keiko
    Yoshino, Takayuki
    Doi, Toshihiko
    Zenda, Sadamoto
    Kawashima, Mitushiko
    Ogino, Takashi
    Hayashi, Ryuichi
    Minami, Hironobu
    Ohstu, Atsushi
    ANNALS OF ONCOLOGY, 2010, 21 : 34 - 34
  • [32] Docetaxel, cisplatin, and fluorouracil;: Docetaxel and cisplatin;: and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma:: A randomized phase II trial of the Swiss Group for Clinical Cancer Research
    Roth, Arnaud D.
    Fazio, Nicola
    Stupp, Roger
    Falk, Stephen
    Bernhard, Juerg
    Saletti, Piercarlo
    Koeberle, Dieter
    Borner, Markus M.
    Rufibach, Kaspar
    Maibach, Rudolf
    Wernli, Martin
    Leslie, Martin
    Glynne-Jones, Robert
    Widmer, Lukas
    Seymour, Matthew
    de Braud, Filippo
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3217 - 3223
  • [33] SAFETY PROFILE OF CHEMOTHERAPY WITH DOCETAXEL AND CISPLATIN FOR RECURRENT OR METASTATIC HEAD AND NECK CANCER
    Shimada, T.
    Kiyota, N.
    Imamura, Y.
    Nishimura, M.
    Funakoshi, Y.
    Tomioka, H.
    Toyoda, M.
    Chayahara, N.
    Mukohara, T.
    Minami, H.
    ANNALS OF ONCOLOGY, 2013, 24
  • [34] ALTERNATING CISPLATIN-5-FLUOROURACIL AND RADIOTHERAPY IN HEAD AND NECK-CANCER
    MERLANO, M
    GRIMALDI, A
    BENASSO, M
    BACIGALUPO, A
    TOMA, S
    SCARPATI, D
    CORVO, R
    SANTELLI, A
    GARAVENTA, G
    ROSSO, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 538 - 542
  • [35] Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer
    Hitt, Ricardo
    Mesia, Ricard
    Lozano, Alicia
    Iglesias Docampo, Lara
    Grau, Juan J.
    Taberna, Miren
    Rubio-Casadevall, Jordi
    Martinez-Trufero, Javier
    del Barco Morillo, Edel
    Garcia Giron, Carlos
    Vazquez Estevez, Sergio
    Cirauqui, Beatriz
    Jesus Cruz-Hernandez, Juan
    ORAL ONCOLOGY, 2022, 134
  • [36] A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck
    Colevas, AD
    Adak, S
    Amrein, PC
    Barton, JJ
    Costello, R
    Posner, MR
    ANNALS OF ONCOLOGY, 2000, 11 (05) : 535 - 539
  • [37] Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck
    Tsukuda M.
    Mikami Y.
    Tanigaki Y.
    Katori H.
    Horiuchi C.
    Ikeda Y.
    Taguchi T.
    Ono M.
    Yoshida T.
    Sakuma Y.
    Aikoh K.
    International Journal of Clinical Oncology, 2004, 9 (3) : 161 - 166
  • [38] An analysis of toxicity in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) receiving cetuximab, fluorouracil and cisplatin alone or with docetaxel in a phase II clinical trial (CeFCiD)
    Knoedler, M.
    Dietz, A.
    Gauler, T.
    Stoehlmacher, J.
    Gruenwald, V
    Rethwisch, V
    Frickhofen, N.
    Haxel, B.
    Schroeder, M.
    Knipping, S.
    Maschmeyer, G.
    Guntinas-Lichius, O.
    Keilholz, U.
    ONKOLOGIE, 2012, 35 : 153 - 153
  • [39] Docetaxel clearance and cisplatin administration: Implications for toxicity of docetaxel, cisplatin, and fluorouracil (DCF) in gastric cancer
    Power, D. G.
    Wu, N.
    Qin, W.
    Sully, D.
    Cisek, C.
    Randazzo, J.
    Ritch, P. S.
    Jhawer, M. P.
    Kelsen, D. P.
    Shah, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] Adjuvant docetaxel, cisplatin and 5-Fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck
    Baghi, M
    Hambek, M
    May, A
    Radeloff, A
    Gstoettner, W
    Knecht, R
    ANTICANCER RESEARCH, 2006, 26 (1B) : 559 - 563
12345